SCHEMBL27721983

SCHEMBL27721983

CC(C)C1CN(OC(=O)C(C)(C)C)CCN1CCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27742729 0.83 SCN1A (0.30)
SCHEMBL27721977 0.83 SCN1A (0.30)
SCHEMBL27722011 0.83 SCN1A (0.30)
SCHEMBL3967084 0.78 NR1H2 (0.37)
SCHEMBL28776242 0.75 DRD3 (0.30)
SCHEMBL27722000 0.74 KEAP1 (0.38)
SCHEMBL28058927 0.69 SMN1; SMN2 (0.35)
SCHEMBL28058913 0.69 SMN1; SMN2 (0.35)
SCHEMBL27721972 0.68 CHRM1 (0.36)
SCHEMBL28058929 0.68 DRD3 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101309918-B [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI 2010-12-29 CN disclosed
CN-101309918-A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI (US) 2008-11-19 CN disclosed